Home
About Us
About Us
Board of Directors
Scientific Advisory Board
Management Team
Careers
For Researchers
Paxalisib
EVT801
Collaborating with Kazia
Publications and Presentations
For Partners
Our Current Partners
What We Are Looking For
For Patients
Accessing Kazia Drug Candidates in Clinical Trials
Accessing Kazia Drug Candidates for Compassionate Use
Resources for Patients
For Investors
Press Releases
ASX Announcements
Delisting from ASX
How to convert unlisted shares to ADSs
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Corporate Governance
Shareholder Services
Media Centre
Overview
Video
Coverage
Contact
Contact Us
Subscribe to email alerts
Heading &
Sub-heading can be edited through HQI
Home
>
For Investors
>
ASX Announcements
Press Releases
ASX Announcements
Delisting from ASX
How to convert unlisted shares to ADSs
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Corporate Governance
Shareholder Services
ASX Announcements
Filter by Year:
2023
2022
2021
2020
2019
2018
29-Aug-2018
Kazia Appendix 4E and financial report
20-Jul-2018
Kazia files shelf registration statement with SEC
16-Jul-2018
Kazia Shareholder Presentation
13-Jul-2018
Kazia divests ATM program
10-Jul-2018
Kazia shareholder information sessions UPDATE
3-Jul-2018
Kazia change in interests of substantial shareholder
25-Jun-2018
Kazia Shareholder Information Sessions
21-Jun-2018
Kazia presents at Gold Coast Investment Showcase
19-Jun-2018
Kazia releases preliminary Cantrixil Phase I data
21-May-2018
Progress Report
Previous
1
2
3
4
5
6
Next
